| Est. tid* | ||
| 2026-11-26 | 16:40 | Kvartalsrapport 2026-Q3 |
| 2026-08-27 | 16:40 | Kvartalsrapport 2026-Q2 |
| 2026-05-27 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
| 2026-05-26 | - | Årsstämma |
| 2026-05-26 | - | Kvartalsrapport 2026-Q1 |
| 2026-02-26 | - | Bokslutskommuniké 2025 |
| 2025-12-10 | - | Split PRLD 100:1 |
| 2025-11-27 | - | Kvartalsrapport 2025-Q3 |
| 2025-11-19 | - | Extra Bolagsstämma 2025 |
| 2025-08-28 | - | Kvartalsrapport 2025-Q2 |
| 2025-06-30 | - | Årsstämma |
| 2025-06-25 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
| 2025-05-30 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-28 | - | Bokslutskommuniké 2024 |
| 2024-11-27 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-28 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-27 | - | Årsstämma |
| 2024-05-17 | - | Kvartalsrapport 2024-Q1 |
| 2024-05-15 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
| 2024-02-21 | - | Bokslutskommuniké 2023 |
| 2023-11-27 | - | Extra Bolagsstämma 2023 |
| 2023-11-27 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-29 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-12 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
| 2023-05-11 | - | Årsstämma |
| 2023-05-11 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-21 | - | Bokslutskommuniké 2022 |
| 2022-11-30 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-29 | - | Kvartalsrapport 2022-Q2 |
| 2022-08-04 | - | Extra Bolagsstämma 2022 |
| 2022-05-23 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
| 2022-05-20 | - | Årsstämma |
| 2022-05-20 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-22 | - | Bokslutskommuniké 2021 |
| 2021-11-23 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-31 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-06 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
| 2021-05-05 | - | Årsstämma |
| 2021-05-05 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-24 | - | Bokslutskommuniké 2020 |
| 2020-11-17 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-28 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-21 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
| 2020-05-20 | - | Årsstämma |
| 2020-05-14 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-13 | - | Bokslutskommuniké 2019 |
| 2019-11-20 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-28 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-16 | - | Årsstämma |
| 2019-05-16 | - | Kvartalsrapport 2019-Q1 |
| 2019-05-10 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
| 2018-11-20 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-28 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-17 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
| 2018-05-16 | - | Årsstämma |
| 2018-05-16 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-14 | - | Bokslutskommuniké 2017 |
| 2017-11-23 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-25 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-22 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
| 2017-05-19 | - | Årsstämma |
| 2017-05-19 | - | Kvartalsrapport 2017-Q1 |
| Land | Sverige |
|---|---|
| Lista | Nordic SME Sweden |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Analysera bolaget i Börsdata!
All ägardata du vill ha finns i Holdings!
Emergers updates analysis of Prolight Diagnostics following positive results from the whole blood study at St Thomas’ Hospital.
Read the article here: https://www.emergers.se/prolight-k25/
For further information, please contact:
Ulf Bladin, CEO
E-mail: info@prolightdx.com
Phone: +46 73 582 39 87
Company website: www.prolightdx.com
About Us
Prolight Diagnostics AB develops innovative Point-of-Care systems. These are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. We want to offer the foremost POC systems on the market for quick, reliable diagnosis of acute events. Our launch product will be for the measurement of high sensitive troponin, to aid in the rule-in and rule-out of myocardial infarction.
The company’s share is traded on the NGM Nordic SME marketplace, under the ticker PRLD.
Emergers publishes updated analysis for Prolight Diagnostics